Wallbrück K, Stellbrink C, Santini M, Gill J, Hartmann A, Wunderlich E
Biotronik GmbH, Technology & Service Center, Erlangen, Germany.
Biomed Tech (Berl). 2002;47 Suppl 1 Pt 2:950-3. doi: 10.1515/bmte.2002.47.s1b.950.
A clinical study investigates the use of Home Monitoring (HM) in pacemaker therapy. For 3 months patients are supervised by daily automatic HM messages. Endpoints are the technical feasibility and the clinical benefit of HM. Ninety three patients have currently been included and followed for 72 +/- 30 days. Three patients were excluded due to insufficient mobile net coverage at their living sites. For the other patients, 5311 of 5911 messages were successfully registered. Interrupts in the sequence of messages occurred 331 times. Two hundred ten of these (63%) lasted just 1 day, 14 interrupts (4%) lasted 5 or more days. Two patients did not show any interrupts, 34 patients (38%) had interrupts of 3 and more days. The clinical benefit of Home Monitoring was found in the remote detection of arrhythmia and lead dislocation.
一项临床研究调查了家庭监测（HM）在起搏器治疗中的应用。在3个月的时间里，患者通过每日自动HM信息进行监测。终点指标是HM的技术可行性和临床益处。目前已纳入93例患者，并随访了72±30天。3例患者因居住地移动网络覆盖不足而被排除。对于其他患者，5911条信息中有5311条成功记录。信息序列中断发生了331次。其中210次（63%）仅持续1天，14次中断（4%）持续5天或更长时间。2例患者未出现任何中断，34例患者（38%）中断持续3天及以上。家庭监测的临床益处体现在心律失常和导线脱位的远程检测中。
